ATE117200T1 - Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit. - Google Patents

Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.

Info

Publication number
ATE117200T1
ATE117200T1 AT92900932T AT92900932T ATE117200T1 AT E117200 T1 ATE117200 T1 AT E117200T1 AT 92900932 T AT92900932 T AT 92900932T AT 92900932 T AT92900932 T AT 92900932T AT E117200 T1 ATE117200 T1 AT E117200T1
Authority
AT
Austria
Prior art keywords
probucol
product containing
medicinal product
fatty acids
increased bioavailability
Prior art date
Application number
AT92900932T
Other languages
English (en)
Inventor
Kenneth G Bassler
Phadke S Deepak
Melissa P Neddermeyer
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE117200T1 publication Critical patent/ATE117200T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
AT92900932T 1990-12-18 1991-11-15 Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit. ATE117200T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62954090A 1990-12-18 1990-12-18

Publications (1)

Publication Number Publication Date
ATE117200T1 true ATE117200T1 (de) 1995-02-15

Family

ID=24523438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900932T ATE117200T1 (de) 1990-12-18 1991-11-15 Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.

Country Status (17)

Country Link
EP (1) EP0563112B1 (de)
JP (1) JP3127998B2 (de)
KR (1) KR0177845B1 (de)
AT (1) ATE117200T1 (de)
AU (1) AU647563B2 (de)
CA (1) CA2097827C (de)
DE (1) DE69106892T2 (de)
DK (1) DK0563112T3 (de)
ES (1) ES2069987T3 (de)
FI (1) FI102457B (de)
GR (1) GR3015837T3 (de)
HU (1) HU210565B (de)
IE (1) IE65578B1 (de)
IL (1) IL100390A (de)
NO (1) NO303526B1 (de)
NZ (1) NZ240961A (de)
WO (1) WO1992010996A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
EP1140036A2 (de) * 1998-12-18 2001-10-10 Abbott Laboratories Neue formulierungen mit lipid regulierenden wirkstoffen
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
AU2571400A (en) * 1999-02-23 2000-09-14 Chugai Seiyaku Kabushiki Kaisha Seam soft capsule preparations containing dihydrobenzofuran derivative
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
US20240000722A1 (en) * 2022-07-01 2024-01-04 Acrotech Biopharma Inc. Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof
CN116617179B (zh) * 2023-05-19 2024-03-29 齐鲁制药有限公司 一种普罗布考软胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862332A (en) * 1967-05-11 1975-01-21 Dow Chemical Co Method of lowering serum cholesterol
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament

Also Published As

Publication number Publication date
FI932769A0 (fi) 1993-06-16
AU9067891A (en) 1992-07-22
KR930702965A (ko) 1993-11-29
NO932236D0 (no) 1993-06-17
NO932236L (no) 1993-06-17
CA2097827C (en) 2002-07-23
EP0563112B1 (de) 1995-01-18
DK0563112T3 (da) 1995-04-10
IL100390A (en) 1996-12-05
CA2097827A1 (en) 1992-06-19
DE69106892T2 (de) 1995-05-18
ES2069987T3 (es) 1995-05-16
GR3015837T3 (en) 1995-07-31
EP0563112A1 (de) 1993-10-06
JPH06503340A (ja) 1994-04-14
IE65578B1 (en) 1995-11-01
HU210565B (en) 1995-05-29
KR0177845B1 (ko) 1999-03-20
AU647563B2 (en) 1994-03-24
HUT64218A (en) 1993-12-28
IE914401A1 (en) 1992-07-01
FI932769A (fi) 1993-06-16
NO303526B1 (no) 1998-07-27
JP3127998B2 (ja) 2001-01-29
FI102457B1 (fi) 1998-12-15
DE69106892D1 (de) 1995-03-02
WO1992010996A1 (en) 1992-07-09
HU9301769D0 (en) 1993-09-28
FI102457B (fi) 1998-12-15
NZ240961A (en) 1994-03-25
IL100390A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
ATE201989T1 (de) Arzneimittel mit kontrollierter wirkstoffabgabe
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
NO934499D0 (no) Ikke-klorfluorcarbonaerosolformuleringer
ATE117200T1 (de) Probucol enthaltendes arzneimittel mit gesteigerter bioverfügbarkeit.
DE69326539D1 (de) Zytotoxische arzneimittel therapie
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
FI904395A0 (fi) 4-hydroxitetrahydropyran-2-oner samt motsvarande dihydroxikarboxylsyra derivat, salter och estrar, foerfarande foer deras framstaellning, deras anvaendning saosom laekemedel, farmaceutiska produkter samt foerprodukter.
DE69228674D1 (de) Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
FI932253A (fi) Foerfarande och anordning foer administration av farmaceutiska partiklarsom kan inandas
FR2686343B1 (fr) Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
ATE181230T1 (de) Niedrigviskose kosmetische und pharmazeutische emulsionen
NO307126B1 (no) Anvendelse av biologisk aktive ureidoderivater for fremstilling av et medikament for bruk i behandlingen av lentivirusindusert sykdom
DE3874142T2 (de) Pharmazeutische zusammensetzung mit antikrebswirkung und methode fuer die behandlung von krebs.
IT1217628B (it) Forma farmaceutica e supporto per la somministrazione di estratti ellergenici
FI944229A (fi) Astyylisalisyylihappoon tai sen suoloihin perustuva puristettu farmaseuttinen annosmuoto oraalista antoa varten ja menetelmä sen valmistamiseksi
KR920005980A (ko) 팽창선 병변의 예방 및 이의 크기를 감소시키기 위한 약제학적 조성물
DZ1600A1 (fr) Compositions pharmaceutiques anti-glaucomateurses et leur procédé d'obtention.
FR2679138B1 (fr) Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
FR2690159B1 (fr) Derives d'acide 3,4-dihydro-2h-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur preparation et les medicaments les contenant.
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน
IT8940141A0 (it) Filo medicato per somministrare localmente medicamenti

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time